- $35.95bn
- $38.39bn
- $2.97bn
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,056 | 1,787 | 1,866 | 2,208 | 2,968 |
Cost of Revenue | |||||
Gross Profit | 814 | 682 | 727 | 863 | 1,153 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 1,599 | 1,410 | 1,473 | 1,711 | 2,343 |
Operating Profit | 457 | 377 | 393 | 497 | 625 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 438 | 365 | 387 | 491 | 555 |
Provision for Income Taxes | |||||
Net Income After Taxes | 360 | 336 | 330 | 391 | 444 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 328 | 314 | 304 | 352 | 404 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 328 | 314 | 304 | 352 | 404 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.39 | 2.29 | 2.21 | 2.55 | 2.91 |
Dividends per Share |